Elk Grove Village, IL (PRWEB) July 29, 2009
Wake Pharma US announced today that clinical evidence on the treatment of wounds using Wound-Be-Gone® will be presented at the National 2009 APMA Annual Scientific Meeting being held in Toronto, Canada July 30 - August 3, 2009. The clinical evidence and data will be presented in podium and with on poster on display during the meeting.
We still want the product Wound-Be-Gone® to be recognized by the physicians, nurses and all the other allied health practitioners who are on the front lines of wound care. With today's economic challenges, people are turning to over-the-counter products, stated Maggie Jankowski, COO of Wake Pharma US. She commented: "Since the launch of Wound-Be-Gone® in June 2008, we have accumulated clinical experience across all types of wounds. Our product is very unique and is, actually, the only over-the-counter product available on the market to effectively treat chronic wounds.
Kim Eldridge, RNFA, CFCN and certified wound nurse for many years stated, "Being the only Over the Counter product of its kind, Wound-Be-Gone® is a new avenue for the treatment of Acute and Chronic wounds in people of all ages. I have seen impressive results in different types of wounds ranging from venous ulcers, burns, post op surgical incisions and abrasions. The pain reduction and minimal scarring that this product offers is unbelievable."
Wound-Be-Gone® is a novel product based on revolutionary technology in the healing of wounds. Based on a unique and patented principle, it is vastly different from current healing products. It has a wide range of uses with essentially no side effect profile or contraindication and contains no antibiotics or material of biological origin.
According to Dr. Richard M. Millis, clinical physiologist, medical educator and V.P. for Research & Development, Wound-Be-Gone® is a novel gel which contains polymer that absorbs excess fluids and, for the first time, removes the toxic free radicals which are responsible for destruction of all living tissues (and aging), thereby creating a protected environment for healing with minimal scarring.
Complications from chronic, complex non-healing wounds can be dire. Not only can they lead to infection and pain, they lead to depression and even limb amputation. Patients affected by these types of wounds often require additional help performing common daily tasks and face higher mortality rates. Wound-Be-Gone® is useful beyond simple wound care.
Literally millions of Americans seek relief each year as complex non-healing wounds are associated with diabetes, pressure ulcers, venous ulcers and non-healing postoperative wounds. Everyone needs access to the "best standard" of care to heal chronic wounds. The new over the counter product Wound-Be-Gone® promises to significantly reduce the overall costs for treating wounds, and restore quality of life.
For more information on Wound-Be-Gone® and its revolutionary wound healing properties, please visit http://www.woundbegone.com
About Wake Pharma US:
Wake Pharma US is an innovative and international company with its own manufacturing facility located in the Czech Republic (European Union). Wake Pharma US specializes in developing, marketing and distribution of revolutionary and unique products to the health market. For further information about Wake Pharma US, please visit our website at http://www.wakepharmaus.com